Subscribe to the Daily PV Brief for breaking drug safety news, regulatory updates, and pharmacovigilance insights.
Daily News and Intelligence for the Pharmacovigilance Industry
Stay informed with timely coverage of drug safety, regulatory developments, safety signals, inspections, AI in pharmacovigilance, compliance trends, and career insights from across the global PV landscape.
Why MHRA’s Weekly Field Safety Notices Still Matter for Safety Monitoring
MHRA’s weekly Field Safety Notices may look routine, but they remain an important visibility tool for device-related safety communication.
Today in PV
A quick scan of the latest stories, safety concerns, regulatory developments, and industry signals every pharmacovigilance professional should know today.
Explore Coverage
Browse the key areas shaping pharmacovigilance today, from global regulatory updates to safety signals, compliance trends, AI, and career growth.
Regulatory Updates
Track key developments from FDA, EMA, MHRA, WHO, NAFDAC, Health Canada, TGA, SAHPRA, and other health authorities.
Inspections & Compliance
Stay current on inspection readiness, CAPAs, SOP expectations, audit trends, and the compliance issues shaping PV systems.
Explainers
Clear, practical breakdowns of PV concepts, industry terms, reporting frameworks, and regulatory changes.
Careers
Insights for professionals building or advancing careers in pharmacovigilance, drug safety, compliance, and related functions.
Safety Signals
Follow emerging risks, label changes, recalls, medication errors, and other safety issues that matter in real-world pharmacovigilance.
AI & Digital PV
Explore how artificial intelligence, automation, and digital tools are influencing case processing, signal detection, and safety operations.
Latest News
Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam. Aque ipsa quae ab illo inventore veritatis. Sed ut perspiciatis unde omnis iste natus error sit voluptatem accus antium doloremque.
MHRA Announces Bayer Recall Over Impurity Above Acceptable Limit
The Bayer recall highlights how quality defects and impurity issues can quickly become part of the pharmacovigilance environment. For PV teams, recalls are not peripheral events. They are part of the broader safety ecosystem that supports patient protection.
MHRA Warns Patients About Fake Mounjaro KwikPen 15mg Pens
The fake Mounjaro warning shows that PV teams need to stay alert not only to adverse events, but also to quality defects, falsified medicines, and unsafe distribution patterns that can create indirect or direct patient harm.
EMA PRAC Warns About Aseptic Meningitis Risk with Ixchiq Vaccine
The Ixchiq review is a useful case study in how signal evaluation can sharpen an already-known risk rather than discover a completely new one. For PV teams, that is a reminder that pharmacovigilance is often about refining the understanding of risk, not just detecting it for the first time.
FDA Recommends Earlier MRI Monitoring for Patients Taking Leqembi
The U.S. Food and Drug Administration has said it is recommending an additional, earlier MRI for patients with Alzheimer’s disease taking Leqembi (lecanemab). The agency stated that this added MRI should occur before the 3rd infusion, in addition to the monitoring...
FDA Warning Letter to Novo Nordisk: What the March 2026 Action Signals for PV Compliance
The FDA issued a warning letter to Novo Nordisk in March 2026 after reviewing compliance with postmarketing adverse drug experience regulations. Here’s why it matters.
EMA’s PRAC Recommends Withdrawal of Levamisole Medicines: A Reminder of How Safety Reviews Can End
EMA’s PRAC has recommended withdrawal of levamisole medicines after concluding that benefits no longer outweigh risks. Here’s why the decision matters for pharmacovigilance.
Featured Posts
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Contact us
Email Us
editor@pvwatchdaily.com